Pharmafile Logo
Pharmafocus logo
Advanced Search

Making remote working work

February 27, 2009
Business Services remote working

There can be all sorts of reasons to work from home, from the usual, such as fitting work around the …

Feature

Ultrasound solution to pharmaceutical pollution

February 27, 2009
Manufacturing and Production Contamination

News

Novartis vaccine recalled after contamination scare

February 26, 2009
Manufacturing and Production, Research and Development Vaccine

Novartis has recalled UK supplies of its meningitis C vaccine after tests found some batches contaminated with bacteria. The recall …

News

Almirall in talks with potential asthma partners

February 26, 2009
Sales and Marketing Almirall, COPD

Spanish pharma company Almirall is in discussions with potential partners for one of its asthma drugs following positive trial results. …

News

Time running out for pharma sales and marketing

February 26, 2009
Research and Development, Sales and Marketing pwC, strategy

The pharma industry's current sales and marketing model will be defunct in the next ten years. That is the stark …

News

Virgo wins major new diabetes launch account

February 26, 2009
Medical Communications Virgo

London-based healthcare PR specialist Virgo Health has won the UK account for new diabetes drug Onglyza. Due to be launched …

News

Europe approves Lilly’s Plavix rival

February 25, 2009
Research and Development, Sales and Marketing Daiichi, Effient, lilly

Lilly and Daiichi Sankyo have won European approval for their blood-thinning drug Efient, which will go up against established blockbuster …

News

Future of new AZ asthma drug uncertain after phase III failure

February 25, 2009
Research and Development AZ, respiratory

News

Genentech urges shareholders to reject Roche bid

February 24, 2009
Sales and Marketing Genentech, Roche

The battle for the future of Genentech has heated up after the company's board asked its shareholders to reject Roche's …

News

NovaBiotics: a rising star for 2009

February 24, 2009
Research and Development NovaBiotics

Biologics company NovaBiotics has been dubbed a Rising Star for 2009 by the Scottish arm of the BioIndustry Association. The …

News

R&D tax credits among anticipated changes for US healthcare

February 24, 2009
Research and Development US, healthcare

With the election of Barack Obama, widespread changes are anticipated for US healthcare and ultimately for the pharmaceutical industry. Although …

News

Bringing global trials teams together

February 23, 2009
Research and Development clinical trials, global

The world is getting bigger and smaller at the same time. When the internet began to really catch on about …

Feature

Roche rejoins ABPI after six-month suspension

February 23, 2009
Sales and Marketing Code of Practice, Roche

Roche has been allowed to rejoin the ranks of the ABPI, after its six-month suspension for bringing discredit on the …

News

Shire acquires ADHD presence in Europe

February 23, 2009
Sales and Marketing ADHD, Shire

Shire has bought the global rights for two established treatments for Attention Deficit Hyperactivity Disorder from UCB. The acquisition gives …

News

CV Therapeutics rejects Astellas takeover bid

February 23, 2009
Sales and Marketing Astellas, CV Therapeutics

Biotech company CV Therapeutics has rejected a second take-over offer from Astellas, saying the Japanese group failed to recognise its …

News

The Pharmafocus interview: Simon Jose

February 20, 2009
Sales and Marketing GlaxoSmithKline, Simon Jose, UK, partnerships, pricing

Like all his contemporaries in the UK, Simon Jose, GlaxoSmithKline’s head of UK   operations has to focus on some of …

Feature

Raptiva suspended in Europe over safety concerns

February 20, 2009
Research and Development, Sales and Marketing Europe, Rapitva

Psoriasis treatment Raptiva is to be suspended from use in the European Union because of concerns about rare but serious …

News

Servier claims victory over NICE in osteoporosis

February 19, 2009
Research and Development, Sales and Marketing NICE, Servier

Servier has claimed victory in the first round of its legal battle against NICE's guidelines on osteoporosis.A judicial review requested …

News

GSK’s diabetes candidate enters phase III

February 19, 2009
Research and Development GSK, diabetes

A large scale study of GlaxoSmithKline's type II diabetes candidate Syncria (albiglutide) has begun.Albiglutide is an investigational biological drug, and …

News

Anger over private firm’s role in prescribing controls

February 19, 2009
NHS

Pharmacy and GP representatives have attacked plans for a private company to oversee primary care prescribing costs.Private provider Assura is …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025